USANA HEALTH SCIENCES INC: Nantahala Capital Management, LLC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Nantahala Capital Management disclosed a stake exceeding 5% in USANA Health Sciences in a Schedule 13G filing with the SEC (accession 0001104659-26-127175). The exact share count and percentage were not specified in the filing headline, but crossing the 5% threshold makes Nantahala a beneficial owner subject to periodic disclosure requirements. The move signals activist or strategic interest in the nutritional supplements maker, whose shares could see attention from investors tracking the fund's position. What to watch next: the full 13G disclosure for precise share counts and any amendments indicating whether Nantahala intends to engage with management or remain a passive holder.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Nantahala Capital Management, LLC, USANA Health Sciences Inc